Predictive Value of CD3, CD8, CD45RO Expression in Stage II/III Colorectal Cancer: Enhancing Predictive Value and Quality of Diagnosis

Theodoros Argyropoulos, Periklis G. Foukas, Effrosyni Karakitsou, Stefanos Konstantoudakis, Maria Kefala, Nektarios Koufopoulos, Nikolaos Machairas, Ioannis Panayiotides and Konstantinos Triantafyllou
Additional contact information
Theodoros Argyropoulos: Department of Pathology, Attikon University General Hospital, Chaidari, Greece
Periklis G. Foukas: 2nd Department of Pathology, National and Kapodistrian University of Athens, Chaidari, Greece
Effrosyni Karakitsou: Department of Biology, University of Barcelona, Barcelona, Spain
Stefanos Konstantoudakis: 2nd Department of Pathology, National and Kapodistrian University of Athens, Chaidari, Greece
Maria Kefala: 2nd Department of Pathology, National and Kapodistrian University of Athens, Chaidari, Greece
Nektarios Koufopoulos: 2nd Department of Pathology, National and Kapodistrian University of Athens, Chaidari, Greece
Nikolaos Machairas: 3rd Department of surgery, National and Kapodistrian University of Athens, Chaidari, Greece
Ioannis Panayiotides: 2nd Department of Pathology, National and Kapodistrian University of Athens, Chaidari, Greece
Konstantinos Triantafyllou: 2nd Department of Medicine, National and Kapodistrian University of Athens, Chaidari, Greece

International Journal of Reliable and Quality E-Healthcare (IJRQEH), 2018, vol. 7, issue 3, 18-36

Abstract: This article describes how colorectal carcinomas (CRC) are the fourth most frequently diagnosed cancer. However, despite advances in specific treatment, approximately 40% to 50% of patients have disease recurrence following potentially curative surgery, highlighting the demand for improvement of staging, treatment and prognosis. Inflammatory infiltration composed of lymphocytes is a common feature found in neoplasms and studies have indicated an association between tumor immune infiltrates and favorable disease outcomes. The aim of this article is to assess the association of tumor infiltrating lymphocytes and DNA damage response expression levels with disease outcome and survival in stage II and III CRC. The authors examined the prognostic value of immunological biomarkers using 5-year follow-up data to train an Artificial Neural Network (ANN) designed for the prediction of personalized risk. Data for three biomarkers which were found significant were subsequently used to train the ANN which predicted 5-year survival with 72.9% sensitivity and 68.8% specificity.

Date: 2018
References: Add references at CitEc
Citations:

Downloads: (external link)
http://services.igi-global.com/resolvedoi/resolve. ... 18/IJRQEH.2018070102 (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:igg:jrqeh0:v:7:y:2018:i:3:p:18-36

Access Statistics for this article

International Journal of Reliable and Quality E-Healthcare (IJRQEH) is currently edited by Anastasius Moumtzoglou

More articles in International Journal of Reliable and Quality E-Healthcare (IJRQEH) from IGI Global
Bibliographic data for series maintained by Journal Editor ().